Cell And Gene Therapy Videos

  1. Navigating Commercial Cell Therapy Manufacturing 11/7/2025

    Explore expert insights on manufacturing strategies, quality management, scalable production, and digital tools that enhance collaboration and ensure consistent, efficient multi-product facility operations.

  2. Making A Meaningful Impact In AAV 11/7/2025

    Viralgen’s Andy Holt at Meeting on the Mesa 2025 highlighted in-house plasmid manufacturing, expanded commercialization development, and cost reduction in gene therapy manufacturing.

  3. A Compact, Flexible, And Easy To Use Benchtop Mixer 11/4/2025

    Compact, flexible, and easy to use, this benchtop mixer supports volumes from 100 mL to 10 L with integrated sensing options and GxP-compatible software, ideal for efficient, reproducible mixing.

  4. Streamline Your Workflow With An Innovative Fixed-Bed System 11/4/2025

    Discover how an innovative fixed-bed system streamlines workflows and supports consistent, high-yield manufacturing across a range of applications.

  5. Scale Your Viral Vector Production With A Streamlined Bioreactor System 11/4/2025

    Scale your viral vector or vaccine production with a streamlined, intermediate-scale bioreactor system that bridges development and commercial manufacturing, supporting applications from exosomes to vaccines.

  6. Enhancing Viral Vector Sterile Filtration: Process Efficiency And GMP Alignment 11/4/2025

    Explore filtration strategies that improve viral vector yield and quality, with insights on AAV and lentivirus workflows, plus practical guidance for implementing PUPSIT in line with requirements.

  7. How To Select The Right Bioanalysis CRO For Your Program 11/3/2025

    The right bioanalysis CRO accelerates progress, while the wrong one can derail outcomes. When every provider claims speed and credibility, how do you confidently choose the right partner?

  8. The Future Of Gene Therapy Production: Enriching Full Capsids, Reducing Costs 10/29/2025

    Explore how intensified upstream processing enriches full AAV capsids, reduces impurities, and lowers manufacturing costs. Learn how extended culture duration drives better outcomes.

  9. Unlocking Allogeneic Cell Therapy: Exploring Durable Approaches 10/22/2025

    Learn how genome engineering and iPSCs are being used to overcome the critical challenges of durability and host immune clearance in both clinical and preclinical settings for allogeneic cell therapies.

  10. From Plasmids To Cell-Free DNA Using Megabulb DNA 10/20/2025

    Discover a non-viral approach for T cell engineering that overcomes limitations of viral transduction. Learn how a novel single-stranded DNA template and CRISPR technology deliver a scalable solution.